![[Free Webinar] Guide to Securing Your Entire Identity Lifecycle Against AI-Powered Threats](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjqbZf4bsDp6ei3fmQ8swm7GB5XoRrhZSFE7ZNhRLFO49KlmdgpIDCZWMSv7rydpEShIrNb9crnH5p6mFZbURzO5HC9I4RlzJazBBw5aHOTmI38sqiZIWPldRqut4bTgegipjOk5VgktVOwCKF_ncLeBX-pMTO_GMVMfbzZbf8eAj21V04y_NiOaSApGkM/s1600/webinar-play.jpg?#)
Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul
Entering trading on Monday, the S&P 500 has declined around 6% since the start of the year. And that's after recovering recently -- it was down much more than that in early April when global tariffs were first announced. But make no mistake, the risk isn't gone, and while a full-blown crash has taken a pause lately, that doesn't mean more of a sell-off isn't coming.The good news, however, is that if you're a long-term investor, a crash in the markets can open up some great buying opportunities. Three stocks that are down over 10% this year and trading at low earnings multiples are Pfizer (NYSE: PFE), PayPal (NASDAQ: PYPL), and Builders FirstSource (NYSE: BLDR). Here's why they may be worth loading up on right now.Investors haven't been all that bullish on Pfizer this year -- it's down 13% thus far in 2025. But it's hard to blame the market for the lack of excitement as the business is struggling to grow these days, as Pfizer expects its top line this year to be nearly unchanged from the previous year, and at worst, it could decline. Continue reading
Entering trading on Monday, the S&P 500 has declined around 6% since the start of the year. And that's after recovering recently -- it was down much more than that in early April when global tariffs were first announced. But make no mistake, the risk isn't gone, and while a full-blown crash has taken a pause lately, that doesn't mean more of a sell-off isn't coming.
The good news, however, is that if you're a long-term investor, a crash in the markets can open up some great buying opportunities. Three stocks that are down over 10% this year and trading at low earnings multiples are Pfizer (NYSE: PFE), PayPal (NASDAQ: PYPL), and Builders FirstSource (NYSE: BLDR). Here's why they may be worth loading up on right now.
Investors haven't been all that bullish on Pfizer this year -- it's down 13% thus far in 2025. But it's hard to blame the market for the lack of excitement as the business is struggling to grow these days, as Pfizer expects its top line this year to be nearly unchanged from the previous year, and at worst, it could decline.
